BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹17 Cr | ₹17 Cr | ₹16 Cr | ₹16 Cr | ₹13 Cr |
What is the latest Contingent Liabilities ratio of BAL PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹17 Cr |
| Mar2024 | ₹17 Cr |
| Mar2023 | ₹16 Cr |
| Mar2022 | ₹16 Cr |
| Mar2021 | ₹13 Cr |
How is Contingent Liabilities of BAL PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹17 Cr | 0.83 | |
| Mar2024 | ₹17 Cr | 3.16 | |
| Mar2023 | ₹16 Cr | 1.18 | |
| Mar2022 | ₹16 Cr | 25.01 | |
| Mar2021 | ₹13 Cr | - | |
Compare Contingent Liabilities of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹137.6 Cr | -4.8% | 0.2% | -9.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -4.8% |
0.2% |
-9.5% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses